ARCHITECT ® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results)
ConclusionsUrinary NGAL was significantly associated with the stage and the grade of kidney cancer. u-NGAL excretion could be considered as a potential biomarker to identify ccRCC patients with the more pejorative outcomes.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chronic Kidney Disease | Clear Cell Carcinoma | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study | Urology & Nephrology